Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

Overview of attention for article published in Molecular Diagnosis & Therapy, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 428)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 8 news stories from 6 outlets.

Ben Fangman, MD, and colleagues provide an overview of the use of circulating tumor DNA levels to detect minimal residual…

00 CEST Biocartis Receives EUR 1.4m Grant to Support Development ofÂ New Idyllaâ„¢ Technology to Unlock Potential in Molecular…

00 CEST B iocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ T echnology to Unlock Potential in Molecular…

PRESS RELEASE 11 May 2021, 07:00 CEST Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ Technology to…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.